Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells

Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commerc...

Full description

Saved in:
Bibliographic Details
Published inAntimicrobial Agents and Chemotherapy Vol. 38; no. 5; pp. 969 - 972
Main Authors CHOCHOLA, J, YAMAGUCHI, Y, MOGUILEVSKY, N, BOLLEN, A, STROSBERG, A. D, STANISLAWSKI, M
Format Journal Article
LanguageEnglish
Published Washington, DC American Society for Microbiology 01.05.1994
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
AbstractList Myeloperoxidase is virucidal to human immunodeficiency virus type 1 (HIV-1) in the persistently infected CEM human T-cell line or in acutely infected human peripheral blood mononuclear cells, as judged by viral infectivity and P24 radioimmunoassay. HIV-1 was specifically inactivated by low doses of the human myeloperoxidase (1.4 to 14.3 mU/ml) and the cells were spared. A higher enzyme concentration (143 mU/m) was cytotoxic, but uninfected CEM cells and normal lymphocytes were resistant to > or = 143 mU of myeloperoxidase per ml. The enzyme was virucidal with the Cl- present in medium and did not require exogenous H2O2. Catalase, an antioxidant enzyme, partially inhibited the virucidal effect of myeloperoxidase. Hence, the H2O2 probably came from the HIV-infected cells themselves. These in vitro findings indicate that the myeloperoxidase system is capable of inactivating HIV-1 of infected cells.
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit StumbleUpon Twitter current issue AAC About AAC Subscribers Authors Reviewers Advertisers Inquiries from the Press Permissions & Commercial Reprints ASM Journals Public Access Policy AAC RSS Feeds 1752 N Street N.W. • Washington DC 20036 202.737.3600 • 202.942.9355 fax • journals@asmusa.org Print ISSN: 0066-4804 Online ISSN: 1098-6596 Copyright © 2014 by the American Society for Microbiology.   For an alternate route to AAC .asm.org, visit: AAC       
Myeloperoxidase is virucidal to human immunodeficiency virus type 1 (HIV-1) in the persistently infected CEM human T-cell line or in acutely infected human peripheral blood mononuclear cells, as judged by viral infectivity and P24 radioimmunoassay. HIV-1 was specifically inactivated by low doses of the human myeloperoxidase (1.4 to 14.3 mU/ml) and the cells were spared. A higher enzyme concentration (143 mU/m) was cytotoxic, but uninfected CEM cells and normal lymphocytes were resistant to greater than or equal to 143 mU of myeloperoxidase per ml. The enzyme was virucidal with the Cl super(-) present in medium and did not require exogenous H sub(2)O sub(2). Catalase, an antioxidant enzyme, partially inhibited the virucidal effect of myeloperoxidase. Hence, the H sub(2)O sub(2) probably came from the HIV-infected cells themselves. These in vitro findings indicate that the myeloperoxidase system is capable of inactivating HIV-1 of infected cells.
Author A D Strosberg
J Chochola
N Moguilevsky
Y Yamaguchi
M Stanislawski
A Bollen
AuthorAffiliation Laboratoire d'Immunologie, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France
AuthorAffiliation_xml – name: Laboratoire d'Immunologie, Institut de Recherches Scientifiques sur le Cancer, Villejuif, France
Author_xml – sequence: 1
  givenname: J
  surname: CHOCHOLA
  fullname: CHOCHOLA, J
  organization: Inst. rech. sci. cancer, lab. immunologie, 94801 Villejuif, France
– sequence: 2
  givenname: Y
  surname: YAMAGUCHI
  fullname: YAMAGUCHI, Y
  organization: Inst. rech. sci. cancer, lab. immunologie, 94801 Villejuif, France
– sequence: 3
  givenname: N
  surname: MOGUILEVSKY
  fullname: MOGUILEVSKY, N
  organization: Inst. rech. sci. cancer, lab. immunologie, 94801 Villejuif, France
– sequence: 4
  givenname: A
  surname: BOLLEN
  fullname: BOLLEN, A
  organization: Inst. rech. sci. cancer, lab. immunologie, 94801 Villejuif, France
– sequence: 5
  givenname: A. D
  surname: STROSBERG
  fullname: STROSBERG, A. D
  organization: CNRS Inst. Cochin, lab. immunologie moléculaire, 75014 Paris, France
– sequence: 6
  givenname: M
  surname: STANISLAWSKI
  fullname: STANISLAWSKI, M
  organization: Inst. rech. sci. cancer, lab. immunologie, 94801 Villejuif, France
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4073885$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/8067778$$D View this record in MEDLINE/PubMed
BookMark eNqFkc-L1DAcxYOsrLOrN69CDiIs2DFp2iQ97GEY1h-w4GX14iGk6Tc7WdpkTNrV-e9NmTLqQTyF8D7f9_LNu0BnPnhA6CUla0pL-W6z2a6ZXNfrhjdP0IqSRha8bvgZWhHCeVFJUj1DFyk9kHyvG3KOziXhQgi5Qt--ujgZ1-keg7VgRhwsHg7Qhz3E8DMLCXDweDcN2mM3DJMPHVhnHHhzwI95OuHxsAdMC-dnA-jwHTbQ9-k5emp1n-DFcl6iL-9v7rYfi9vPHz5tN7eFrhoxFmBJV7as7IgkHQhqSAUgwBpW0lbYuums5TmTtszWnWW8YppREMw0raSsZpfo-ui7n9oBOgN-jLpX--gGHQ8qaKf-VrzbqfvwqKhc5t8s8zF8nyCNanBp3kB7CFNSgnNR1SX9L0h5U7KKzeDbI2hiSCmCPT2GEjWXpnJpiklVq1xaxq-OuE5DqR7CFH3-r3-xr_5c9mS8NJr114uuk9G9jdobl05YRQSTct4ZH7Gdu9_9cBFUzlZam99JvwCAdLr5
CODEN AACHAX
CitedBy_id crossref_primary_10_1038_s41598_020_75357_2
crossref_primary_10_1046_j_1365_2672_1999_00652_x
crossref_primary_10_1046_j_1365_2672_2003_02071_x
crossref_primary_10_1016_j_freeradbiomed_2006_01_037
crossref_primary_10_1371_journal_pone_0066073
crossref_primary_10_1089_aid_1996_12_25
crossref_primary_10_1002_biot_201200313
crossref_primary_10_1002_jmv_2132
crossref_primary_10_1080_08910600701343286
crossref_primary_10_31640_LS_2016_1_2_03
crossref_primary_10_1007_s12223_013_0239_5
crossref_primary_10_1016_j_fsi_2015_05_014
crossref_primary_10_23736_S2724_5276_20_05748_5
crossref_primary_10_1016_j_prrv_2016_03_007
crossref_primary_10_1099_jmm_0_047589_0
crossref_primary_10_3109_10715769509064034
crossref_primary_10_3390_biotech12020033
crossref_primary_10_1007_s10616_009_9181_4
ContentType Journal Article
Copyright 1994 INIST-CNRS
Copyright_xml – notice: 1994 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7T5
7U9
H94
7X8
5PM
DOI 10.1128/AAC.38.5.969
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
MEDLINE - Academic
DatabaseTitleList
CrossRef


MEDLINE
AIDS and Cancer Research Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
Biology
EISSN 1098-6596
EndPage 972
ExternalDocumentID 10_1128_AAC_38_5_969
10.1128/AAC.38.5.969
8067778
4073885
aac_38_5_969
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
.55
.GJ
08R
0R~
23M
2WC
39C
3O-
4.4
53G
5GY
5RE
5VS
6J9
AAPBV
AAUGY
ACGFO
ADBBV
AENEX
AFMIJ
AGNAY
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HH5
HYE
HZ~
H~9
IQODW
J5H
K-O
KQ8
L7B
LSO
MVM
NEJ
O9-
OK1
P2P
RHF
RHI
RNS
RPM
RSF
TR2
UHB
VH1
W2D
W8F
WH7
WHG
WOQ
X7M
X7N
XOL
Y6R
ZA5
ZGI
ZXP
~A~
AGVNZ
CGR
CUY
CVF
ECM
EIF
NPM
-
0R
55
A
ABFLS
ADACO
ADBIT
BXI
GJ
HZ
AAYXX
CITATION
7T5
7U9
H94
7X8
5PM
ID FETCH-LOGICAL-a497t-ef0d2b32d080de71c04ee7efc321b7f59dff6def1b3f5df3643a31e73c9b81353
IEDL.DBID RPM
ISSN 0066-4804
IngestDate Tue Sep 17 21:24:44 EDT 2024
Fri Oct 25 09:41:16 EDT 2024
Sat Oct 26 00:58:51 EDT 2024
Thu Sep 12 17:07:19 EDT 2024
Tue Dec 28 13:59:03 EST 2021
Sat Sep 28 08:38:57 EDT 2024
Sun Oct 29 17:09:04 EDT 2023
Wed May 18 15:37:51 EDT 2016
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Cell culture
HIV-1 virus
Enzyme
Retroviridae
Cytotoxicity
In vitro
Virus
Cell line
Sensitivity resistance
T-Lymphocyte
Lentivirinae
Antiviral
Human immunodeficiency virus
Infected cell
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-a497t-ef0d2b32d080de71c04ee7efc321b7f59dff6def1b3f5df3643a31e73c9b81353
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
OpenAccessLink https://europepmc.org/articles/pmc188135?pdf=render
PMID 8067778
PQID 16923431
PQPubID 23462
PageCount 4
ParticipantIDs crossref_primary_10_1128_AAC_38_5_969
proquest_miscellaneous_76674521
pubmed_primary_8067778
highwire_asm_aac_38_5_969
proquest_miscellaneous_16923431
pascalfrancis_primary_4073885
asm2_journals_10_1128_AAC_38_5_969
pubmedcentral_primary_oai_pubmedcentral_nih_gov_188135
PublicationCentury 1900
PublicationDate 1994-05-01
PublicationDateYYYYMMDD 1994-05-01
PublicationDate_xml – month: 05
  year: 1994
  text: 1994-05-01
  day: 01
PublicationDecade 1990
PublicationPlace Washington, DC
PublicationPlace_xml – name: Washington, DC
– name: United States
PublicationTitle Antimicrobial Agents and Chemotherapy
PublicationTitleAlternate Antimicrob Agents Chemother
PublicationYear 1994
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
SSID ssj0006590
Score 1.5762407
Snippet Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
Myeloperoxidase is virucidal to human immunodeficiency virus type 1 (HIV-1) in the persistently infected CEM human T-cell line or in acutely infected human...
SourceID pubmedcentral
proquest
crossref
asm2
pubmed
pascalfrancis
highwire
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 969
SubjectTerms AIDS/HIV
Antibiotics. Antiinfectious agents. Antiparasitic agents
Antiviral Agents
Antiviral Agents - pharmacology
Biological and medical sciences
Catalase - pharmacology
Cell Line
Glucose Oxidase - pharmacology
HIV Core Protein p24 - immunology
HIV Core Protein p24 - metabolism
HIV-1
HIV-1 - drug effects
HIV-1 - metabolism
human immunodeficiency virus 1
Humans
Lactoperoxidase - pharmacology
Medical sciences
Peroxidase
Peroxidase - pharmacology
Pharmacology. Drug treatments
Phytohemagglutinins - pharmacology
Radioimmunoassay
Research Article
T-Lymphocytes
T-Lymphocytes - drug effects
T-Lymphocytes - microbiology
Title Virucidal effect of myeloperoxidase on human immunodeficiency virus type 1-infected T cells
URI http://aac.asm.org/content/38/5/969.abstract
https://www.ncbi.nlm.nih.gov/pubmed/8067778
https://journals.asm.org/doi/10.1128/AAC.38.5.969
https://search.proquest.com/docview/16923431
https://search.proquest.com/docview/76674521
https://pubmed.ncbi.nlm.nih.gov/PMC188135
Volume 38
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL2ilYb2gqAwEWDDQrCnJU3ixHYeq4ppAhUVqUOTeLCS2BaRaDItHaL_nus46VbEXnh27Hyca_vYOT4X4H2WmYgpXvo8yXM_MVz5BUNAQq7jrBCch50dw-ILu7hMPl2lV_2hsLaXVdZlUQX1z3VQVz86beX1upwOOrHpcjGPhIhoOh3BCONzWKH3oy9L3b4KTqV-IsJkELvHYjqbzQMqgjTIWHYIB8Kap9n0auO8Xcf789LgFWylknmLX8u4NBf_4qF_yynvzU_nT-FJTyzJzL3AM3ik6wkcuFST2wk8XvQ_0SdwunR21dszsro7fdWekVOyvDOy3j6H798qRL5S2KyTfZDGkPXWioz0TfMbC1pNmpp0ef5IZU-aNEpbSwp7npP8wtotsXu8JPKd6EsrsiL2X0H7Ai7PP67mF36fjMHPk4xvfG1CFRc0VkgxleZRGSZac21KGkcFN2mmjGF4j6igJlWGItPJaaQ5LRFym1zjCMZ1U-uXQEqWI03TKVIlHD9iVRRJGWJtGqnYDhEevLOIyL43tbJbqMRCIoCSCplKBNCDDwNe8toZczxwnTeAKbFVmeflvbLjPXR3DeEqlwqRevB2QFtir7OfJ691c4tPxJAYI_d6-ArOGE-QG3lw5KJj13gfdx6wvbDZlVvD7_0S7Aed8beL-1f_W_E1HDonaCvXfAPjzc2tPkZKtSlOYPT5qzjpetIfm3UhcA
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Bb9MwFH6CosEuCAoTAcYsBDstaRIntnOsKqYC69RDhyZxsJLYFpVoMi0dov-e5zjpVsQunF_stPn87M_J5-8BfMgyEzHFS58nee4nhiu_YAhIyHWcFYLzsLVjmJ2z6UXy5TK97A6FNZ2ssiqLZVD9XAXV8kerrbxalaNeJzaazyaREBFNRw_hEaZrmPR79G7-Zal7s4KLqZ9guJe7x2I0Hk8CKoI0yFi2D3vC2qfZAmuDvFnFuytT7xZsxZJ5g8_LuEIX_2Kifwsq76xQp8_gaUctydj9hefwQFdD2HPFJjdDeDzrPqMP4XjuDKs3J2Rxe_6qOSHHZH5rZb15Ad-_LRH7pcJunfCD1IasNlZmpK_r3xhoNKkr0lb6I0t71qRW2ppS2BOd5Be2boh9y0si38m-tCILYr8WNC_h4vTTYjL1u3IMfp5kfO1rE6q4oLFCkqk0j8ow0ZprU9I4KrhJM2UMw3tEBTWpMhS5Tk4jzWmJoNvyGgcwqOpKvwJSshyJmk6RLOEMEquiSMoQW9NIxXaS8OC9RUR2-dTIdqsSC4kASipkKhFADz72eMkrZ81xz3VeD6bEXmWel3dihzvobjvCfS4VIvXgqEdbYt7Zx5NXur7BX8SQGiP7uv8KzhhPkB15cOBGx7bzbtx5wHaGzTZuLb93I5gJrfW3G_mv_7fhETyZLmZn8uzz-dc3sO98oa148y0M1tc3-hAJ1rp41-bTHyKVI9E
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1db9MwFL0aRZv2gqAwLcCYhWBPS5vEie08VoVqfHTqQ4cm8WAlsS0q0aRaOkT_Pddx0q2IvfDs2Pk4vvaxc3wuwLs0NSFTvPB5nGV-bLjyc4aABFxHaS44Dxo7huklu7iKP18n13sgurMwjWi_yBeD8udyUC5-NNrK1bIYdjqx4Ww6DoUIaTJcKTN8BI8xZAPWrdPbMZglbncFJ1Q_FkHcSd4jMRyNxgMqBskgZekh7AtroWaTrPWyehntzk6dY7AVTGY1fjPjkl38i43-Laq8N0tNnsKTll6SkXuNZ7Cnyz7su4STmz4cTNtf6X04mznT6s05md-dwarPyRmZ3dlZb57D928LxH-hsFkn_iCVIcuNlRrpm-o3FtSaVCVpsv2RhT1vUiltjSnsqU7yC2vXxO70ktB30i-tyJzYPwb1C7iafJyPL_w2JYOfxSlf-9oEKspppJBoKs3DIoi15toUNApzbpJUGcPwHmFOTaIMRb6T0VBzWiDwNsXGEfTKqtTHQAqWIVnTCRImHEUiledxEWBtGqrIDhQevLWIyDamatksVyIhEUBJhUwkAujB-w4vuXL2HA9c53VgSmxVZllxr-xkB91tQ7jWpUIkHpx2aEuMPft5slJXt_hEDOkxMrCHr-CM8RgZkgdHrndsG2_7nQdsp9tsy63t924JRkNj_-16_8v_rXgKB7MPE_n10-WXV3DorKGtfvM19NY3t_oEOdY6f9OE0x9JiCTk
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Virucidal+effect+of+myeloperoxidase+on+human+immunodeficiency+virus+type+1-infected+T+cells&rft.jtitle=Antimicrobial+Agents+and+Chemotherapy&rft.au=J+Chochola&rft.au=Y+Yamaguchi&rft.au=N+Moguilevsky&rft.au=A+Bollen&rft.date=1994-05-01&rft.pub=American+Society+for+Microbiology&rft.issn=0066-4804&rft.eissn=1098-6596&rft.volume=38&rft.issue=5&rft.spage=969&rft_id=info:doi/10.1128%2FAAC.38.5.969&rft_id=info%3Apmid%2F8067778&rft.externalDBID=n%2Fa&rft.externalDocID=aac_38_5_969
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0066-4804&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0066-4804&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0066-4804&client=summon